Gamma Knife Radiosurgery on the Trigeminal Root Entry Zone for Idiopathic Trigeminal Neuralgia: Results and a Review of the Literature by 박소희 & 장진우
111www.eymj.org
INTRODUCTION
Trigeminal neuralgia (TN) is defined by the International Head-
ache Society as “recurrent unilateral brief electric shock-like 
pains, abrupt in onset and termination, limited to the distribu-
tion of one or more divisions of the trigeminal nerve and trig-
gered by innocuous stimuli.”1 It is characterized by the pres-
ence of a trigger zone, no objective neurological deficit, and no 
other identified causes of facial pain; it can cause severe pain 
and disrupt or impair quality of life in patients.2
Treatments for TN consist of pharmacological treatments, 
such as that with carbamazepine; surgical treatments, includ-
ing open surgery and percutaneous procedures; and radiosur-
gery, including gamma knife radiosurgery (GKRS). Historical-
ly, GKRS was introduced as a treatment for TN. The Swedish 
neurosurgeon Lars Leksell began treating TN patients in 1951 
using a prototype guiding device linked to a dental X-ray ma-
chine.3 Lindquist reported on the progress of TN patients who 
had undergone GKRS in 1991, and several studies have docu-
mented the safety and efficacy of GKRS, including long-term 
results, for TN.4-6 Other techniques of radiosurgery, such as cy-
ber knife surgery and linear accelerator, were introduced in the 
2000s and have shown effectiveness, compared to other surgi-
cal treatments.7,8
Several modifications have been made to the treatment regi-
mens for GKRS over the past few decades. We reviewed the ra-
tionale, effects, safety, and current treatment policies of GKRS 
for TN in view of our institution’s results and a review of the lit-
erature to date.
PATHOPHYSIOLOGY OF TN
The pathogenesis of TN is not fully understood, and its exact 
pathophysiology remains controversial. However, in general, 
it is described by a mixed peripheral and central mechanism.9 
Neurovascular conflict is the most accepted theory, as it is related 
to TN in a vast majority of cases.10 Chronic nerve compression 
results in demyelination of trigeminal sensory fibers within the 
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proximal nerve root, with progressive axonal degeneration.11 
Demyelination can lead to ephaptic transmission, and the reen-
try mechanism causes an amplification of sensory inputs.10,12 
Meanwhile, nerve injury leads to a release of mediators that sen-
sitize peripheral nerve terminations, resulting in neurochemical 
and phenotypic changes and increased excitability of trigemi-
nal neurons and trigeminal nuclei (central sensitization).11 Ultra-
structural and biochemical changes in axons and myelin are 
seen in the root, the Gasserian ganglion, or both.13
CLINICAL FEATURES AND 
CLASSIFICATION
According to the International Classification of Headache Dis-
orders, 3rd edition (ICHD-3), TN can be diagnosed when recur-
rent paroxysms of unilateral facial pain of a severely intense, 
electric shock-like, shooting, stabbing, or sharp nature occurs 
in one or more divisions of the trigeminal nerve.1 It should not 
radiate beyond the territory of the trigeminal nerve, should last 
between 1 second and 2 minutes, and should be precipitated 
by innocuous stimuli within the affected trigeminal distribu-
tion. TN is divided into the following three categories accord-
ing to its cause: classical TN, secondary TN, and idiopathic TN. 
Classical TN refers to cases without an apparent cause other 
than neurovascular compression. When underlying diseases are 
present, such as a tumor in the cerebellopontine angle, arterio-
venous malformation, or multiple sclerosis, secondary TN is di-
agnosed. Idiopathic TN could be diagnosed in cases where nei-
ther an electrophysiological test nor magnetic resonance images 
show significant abnormalities. Besides the ICHD classification, 
the Burchiel classification is also used to categorize TN and re-
lated facial pain syndromes using the characteristics of pain.14 
The classification is based on the patient’s history and is shown 
in Table 1.
GKRS AS A TREATMENT METHOD
Treatment method for TN
Treatments for TN are divided into the following three catego-
ries: pharmacological treatments; surgical treatments, includ-
ing microvascular decompression (MVD) and percutaneous 
procedures, such as radiofrequency rhizotomy (RFR), balloon 
microcompression, and glycerol injection; and stereotactic ra-
diosurgery.
The first therapeutic line is pharmacological treatment with 
carbamazepine. It is the only drug shown in a random-controlled 
trial to reduce the intensity and frequency of attacks, and it pro-
vides significant pain control in 80–85% of patients.15 Never-
theless, its efficacy can decrease, and in the long term, many 
patients become drug-resistant.16 Oxcarbazepine, baclofen, la-
motrigine, and pimozide can also be used.17 
Surgical treatment is the second therapeutic line and includes 
open surgery, percutaneous surgery, and radiosurgery. It is used 
in patients with medically intractable pain or those who suffer 
from side effects related to medication. MVD alleviates the un-
derlying cause of a compressed trigeminal nerve root through 
exploration of the posterior fossa. It is considered a reference 
treatment modality, as it provides pain relief for approximately 
90% of patients and has long-term effects (68–88% after 5 years 
and 61–88% after 10 years).18,19 Therefore, MVD should be con-
sidered as the first surgical treatment modality for young pa-
tients with an obvious neurovascular conflict.20 However, major 
complications of surgery can include hearing loss, cerebrospi-
nal fluid leakage, infection, hemorrhage, and brainstem infarc-
tion.18,21
Percutaneous procedures are ablative techniques performed 
at the level of the Gasserian ganglion and are mechanistically 
based on physical, thermic, and chemical actions. Percutane-
ous procedures show a high initial success rate; however, over 
time, the recurrence rate is higher than that of MVD.22 The ini-
tial success rate for balloon microcompression was reported 
at 82–99%, and the median pain-free time was 20 months.23,24 
For glycerol injection, the initial success rate and the median 
pain-free time were 73–96% and 21 months, respectively.24,25 For 
RFR, the initial success rate was 78.8–100%, and the probabili-
ties of remaining pain-free 1, 2, and 11 years after the procedure 
were 65%, 49%, and 26%, respectively.26-28 These ablative pro-
cedures pose a risk of hypesthesia, dysesthesia, severe facial 
numbness, corneal keratitis, and masseter muscle weakness.29,30
Lastly, GKRS can be used for drug-resistant TN patients who 
are poor surgical candidates due to medical comorbidities or 
age or for those who refuse invasive therapy, especially in the 
absence of other primary indications, such as neurovascular 
conflict. GKRS has a very high rate of pain relief with minimal 
complications, showing a gradual decline in the complication 
rate due to advancement in imaging modalities.22 Burchiel’s type 
1 and type 2 TN are the most common indications of GKRS. 
GKRS may also be used in selected cases of multiple sclerosis-
related and post-herpetic TN and in some cases of atypical fa-




>50% episodic pain, sharp, shooting,  
  electrical shock-like
TN, Type 2
>50% constant pain, aching, throbbing, 
  burning
Trigeminal injury
Trigeminal neuropathic pain Unintentional, incidental trauma
Trigeminal deafferentation pain Intentional deafferentation
Symptomatic TN Multiple sclerosis
Postherpetic neuralgia Trigeminal Herpes zoster outbreak
Atypical facial pain Somatoform pain disorder
TN, trigeminal neuralgia.
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cial pain.31,32
Institutional results on GKRS for TN
A total of 235 patients underwent GKRS for TN between Feb-
ruary 1996 and September 2018. The indications for GKRS in-
cluded failure of pharmacological treatment, significant adverse 
effects from medication, and failure of prior surgical treatment. 
Of these patients, 157 had charts and a follow-up period of more 
than 1 year. Of these patients, except for those with TN related 
to tumors and multiple sclerosis, 142 patients were reviewed 
(Fig. 1). Patient characteristics are shown in Table 2. GKRS was 
performed with a Gamma Knife (Leksell Gamma Knife, Elekta 
Instruments, Atlanta, GA, USA). Seven patients were treated with 
the Gamma Knife Model B, 28 patients with the Gamma Knife 
Model C, and 107 patients with the Perfexion Gamma Knife.
GKRS treatment was planned using T2-weighted magnetic 
resonance images with a slice thickness of 1 mm and construc-
tive interference in steady-state images with 0.5-mm axial slic-
es obtained with the stereotactic frame fixed to the head under 
local anesthesia. A single 4-mm isocenter with two or three beam 
blocking was used for treatment. It was positioned to cover the 
trigeminal root entry zone (REZ). After February 2005, planning 
was done such that a 15-Gy isodose line invaded less than 5% 
of the brainstem. The dose used varied from 60 to 90 Gy.
Pain from TN was assessed using Barrow Neurologic Institute 
(BNI) pain scores. BNI scores of I–IIIb were considered as indic-
ative of successful treatment, whereas BNI pain scores of IV and 
V were considered reflective of unsuccessful treatment. Fol-
lowing improvements in pain after GKRS, any worsening of the 
pain (even if the level of pain was milder than that present pri-
or to treatment) was considered as recurrence.
The median follow-up period was 37 months (12–250 months, 
54.35±49.51 months). The median dose of gamma rays was 85 
Gy (60–90 Gy, 84.23±3.743 Gy). After GKRS, 93.7% of patients 
(133/142) experienced successful treatment (Fig. 2). Of these, 
recurrence of pain occurred in 50 patients (37.6%, 50/133), and 
the median time to recurrence was 29 months (2–166 months, 
42.26±38.08 months). Among patients who experienced recur-
rence, six (12%, 6/50) needed additional surgery or procedures, 
and the rest were controlled by medication. Complications were 
reported in a total of 25 patients (17.6%, 25/142) and included 
facial hypesthesia in 19 patients (13.4%), dysesthesia in 2 pa-
tients (1.4%), and dry eye syndrome in 4 patients (2.8%) (Table 
3). Univariate comparisons were performed using the indepen-
dent t-test and one-way ANOVA test. There were no statistically 
significant correlations between the prior procedure and com-
plications (p=0.068) or between the types of prior procedures 
and complications (p=0.705). There were also no statistically sig-
nificant relationships between dose and successful treatment, 
recurrence, and complications under significance of p<0.05.
Pain relief after GKRS
The rationale for achieving pain relief after GKRS is related to 
focal axonal degeneration of the trigeminal nerve associated 
TN treated with GKRS
from Feb 1996 to Sep 2018, n=235
Included patients, n=142
Excluded unidentifiable charts, n=25
Excluded at follow-up period (less than 1 year), n=53
Excluded TN related to tumor and MS, n=15
Fig. 1. Flow chart for patient inclusion. TN, trigeminal neuralgia; GKRS, 
Gamma Knife radiosurgery; MS, multiple sclerosis.
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V2, 3 30 (21.13)
V1, 2, 3 11 (7.75)



















Fig. 2. Predicted pain relief maintenance period after Gamma Knife ra-
diosurgery. Solid line represents predicted pain relief maintenance pe-
riod and dotted line represents 95% confidence interval.
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with nociceptive sensibility, destruction of ionic channels, and 
electrophysiological blocking initially after nerve irradiation.33,34 
Additionally, a delayed radiation effect with axonal degenera-
tion has been proposed, as some patients experience a late re-
sponse after GKRS.35 In the literature, the latency to pain relief 
was 15 to 78 days on average, and the maximum time to pain re-
lief was 6 months after treatment.29
Table 4 lists studies with more than 100 patients who under-
went GKRS for TN (Fig. 3). GKRS showed high rates of pain re-
lief, ranging from 70–98% in large studies of over 100 patients 
(Fig. 4). Pain control was achieved in 69–85% of cases at 1 year, 
59% at 2 years, and 38–52% at 5 years.35,36 Regarding long-term 
results, rates of pain control maintenance were 32–59.7% at 7 
years and 30–45.3% at 10 years.5,6,37 Although follow-up periods 
vary among the studies, making direct comparison difficult, the 
average pain free duration was 7–58 months.35,38,39 The mean 
recurrence rate was 26.9%, with a range of 3.3–45.1% (Fig. 5). 
In comparison, our data showed a higher recurrence rate than 
the average. This may be due to a difference in follow-up peri-
ods, because in our study, some patients experienced recurrent 
pain after approximately 14 years. 
Complications of GKRS
Complications due to GKRS are uncommon, with hypesthesia 
being the most common adverse event. The incidence of hyp-
esthesia is reported to be up to 2.7–55.0%, with a mean occur-
rence rate of 22.55%, slightly higher than our result (Table 4). 
Similar to the latency period for GKRS to be effective, there may 
also be a latency period between the procedure and the devel-
opment of complications. The mean time to hypesthesia occur-
rence ranged from 6 to 36 months.29
Other complications include dysesthesia, deafferentation 
pain, dysgeusia, dry eye syndrome, keratitis, hearing impair-
ment, and masticator weakness.41,42 Rarely, significant injury to 
Table 3. Results of Gamma Knife Radiosurgery for Trigeminal Neuralgia
Treatment outcome Number of patients (%)
Treatment failure (BNI pain score IV, V) 9 (6.3)





Dry eye syndrome 4 (2.8)
BNI, Barrow Neurological Institute.
Table 4. Review of Studies with more than 100 Cases of Gamma Knife Radiosurgery for Trigeminal Neuralgia
Study (year) Number of patients
Mean or median follow-up  
period (months)
Pain relief (%) Complications (%) Recurrence (%)
Young, et al. (1998)66 110 19.8 95.5 2.7 3.3
Maesawa, et al. (2001)35 220 22 78.6 10.2 13.6
Pollock, et al. (2002)42 117 26 75 37 16
Petit, et al. (2003)67 112 30 77 7.3 29
Sheehan, et al. (2005)68 136 19 70 19 24
Urgosik, et al. (2005)38 107 60 96 20 25
Longhi, et al. (2007)40 170 37.4 90 8.75 18
Fountas, et al. (2007)48 106 34.3 89.6 16 32.1
Kondziolka, et al. (2010)5 503 24 89 10.5 42.9
Hayashi, et al. (2011)69 130 38 98 24 18.0
Marshall, et al. (2012)44 448 20.9 86 44 40
Young, et al. (2013)47 315 68.9 85.6 32.9 14.3
Lucas, et al. (2014)70 446 21.2 84.5 42 45.1
Régis, et al. (2016)6 497 43.8 91.75 21.1 34.4
Taich, et al. (2016)49 263 24 79 NA 39.8
Martínez Moreno, et al. (2016)71 117 66 91 32.5 19
Zhao, et al. (2018)50 247 49.7 87.9 31.9 3.6
Gagliardi, et al. (2018)72 166 64.7 78 24 31.2
Lee, et al. (2018)73 108 17 80 55 22
Included studies, n=19
A systemic review of English-language literature using PubMed database
•  Searching terms, “Trigeminal neuralgia” and “Gamma Knife” in screening of 
titles and/or abstracts
•  Until September 2019
•  Large studies of over 100 patients
•  Exclude sudies without mean or median follow-up period, 
pain relief rate, or recurrence rate
Fig. 3. Flow chart for inclusion of studies analyzing pain relief, complica-
tion, and recurrence rates.
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adjacent vasculature due to high doses have been reported.43 
Terms used in each article related to complications had a lack 
of precision; hence, there may be differences in the rate of com-
plications. Studies have reported dysesthesia in 0–16%, pares-
thesia in 0–13%, deafferentation pain in 0–3.3%, dry eye syn-
drome in 0–22.4%, and keratitis in 0–7%.44-47 
Complications were not associated with the prior procedure 
in previous studies, which is consistent with our results.48-50 This 
may be due to some differences in the mechanisms of compli-
cations in destructive procedures, such as GKRS, versus non-
destructive procedures, such as MVD. Also, in MVD and other 
destructive procedures, such as RFR, the duration of complica-
tions is short, which does not seem to affect complications in a 
subsequent surgery. However, in the case of radiosurgery, there 
is a report that previous radiosurgery affects complications be-
cause there is a latency period of radiosurgery.49
Several studies have shown that complication rates are asso-
ciated with the target selection, the length of the irradiated nerve, 
and the dose.42,51,52 Our study showed a complication rate simi-
lar to that in previous studies, and complications due to GKRS 
do not appear to be statistically related to the high dose used.
Repeat GKRS
Due to the low incidence of complications associated with GKRS, 
rather than other procedures, repeat GKRS may be considered 
for pain recurrence. Repeat GKRS appears to have a similar ef-
ficacy to initial GKRS for TN, with rates of complete and partial 
pain relief ranging from 78% to 85%.51,53,54 There is a report that 
prior GKRS is associated with bothersome facial numbness af-
ter GKRS. The main complications after repeat GKRS are new 
facial sensory symptoms caused by partial trigeminal nerve in-
jury, seen in 11–69% of patients.54-56 
Therefore, to reduce complications due to repeat GKRS, de-
creasing the dose of the second GKRS would be helpful, as would 
moving the target to not overlap with the previous target, so that 
a previously treated nerve is not exposed to a high dose of ra-
diation.54
GKRS policy: dose and target
When GKRS was first used for TN, Leksell3 targeted the Gasse-
rian ganglion. After that, Lindquist, et al.4 reported the results 
of GKRS targeting the Gasserian ganglion in 1991 and then stat-
ed the results of treatment of the trigeminal REZ, where periph-
eral myelination with Schwann cells transits to central myelin-
ation with oligodendrocytes. Rand, et al.57 reported the results 
of the GKRS targeting the retrogasserian area, anterior to REZ, 
in 1993. Since then, both the REZ and retrogasserian area have 
been used to treat TN with GKRS (Fig. 6). 
Our study 2019
Young, et al. (1998)66
Maesawa, et al. (2001)35
Pollock, et al. (2002)42
Petit, et al. (2003)67
Sheehan, et al. (2005)68
Urgosik, et al. (2005)38
Longhi, et al. (2007)40
Fountas, et al. (2007)48
Kondziolka, et al. (2010)5
Hayashi, et al. (2011)69
Marshall, et al. (2012)44
Young, et al. (2013)47
Lucas, et al. (2014)70
Régis, et al. (2016)6
Taich, et al. (2016)49
Martínez Moreno, et al. (2016)71
Zhao, et al. (2018)50
Gagliardi, et al. (2018)72
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Pain relief rate (%)
Fig. 4. Forest plot of pain relief rates in 19 studies. Confidence intervals were calculated at a confidence level of 95% for a single proportion.
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Our study 2019
Young, et al. (1998)66
Maesawa, et al. (2001)35
Pollock, et al. (2002)42
Petit, et al. (2003)67
Sheehan, et al. (2005)68
Urgosik, et al. (2005)38
Longhi, et al. (2007)40
Fountas, et al. (2007)48
Kondziolka, et al. (2010)5
Hayashi, et al. (2011)69
Marshall, et al. (2012)44
Young, et al. (2013)47
Lucas, et al. (2014)70
Régis, et al. (2016)6
Taich, et al. (2016)49
Martínez Moreno, et al. (2016)71
Zhao, et al. (2018)50
Gagliardi, et al. (2018)72
Lee, et al. (2018)73
Total
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Recurrence rate (%)
Fig. 5. Forest plot of complication rates in 19 studies. Confidence intervals were calculated at a confidence level of 95% for a single proportion.
Fig. 6. Targets used in Gamma Knife radiosurgery for trigeminal neuralgia. Retrogasserian area (A) and trigeminal root entry zone (B).
A B
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There is still controversy regarding which target is better. The 
major difference between the targets is the dose received by 
the REZ and the brainstem. However, the effect and complica-
tions related to the target and the dose are not established. Sev-
eral studies have compared the complications and effects be-
tween anterior and posterior targets.58-60 They reported that an 
anterior target has lower complications than a posterior target, 
showing similar or better pain relief. However, since there is a 
difference between doses among studies and targets and the 
appropriate dose has not yet been established for the target, it 
is difficult to directly determine which target is better.
Determination of the treatment dose may vary according to 
the target. However, studies have shown that a dose of 70 Gy 
failed to control pain in 100% and that radiation below 70 Gy 
had little effect on the structure of the trigeminal nerve.61,62 A 
radiation dose of more than 80 Gy causes partial degeneration 
with loss of axons and demyelination, which is the mechanism 
of pain relief in GKRS.62 Therefore, GKRS with 80 Gy or higher is 
usually performed. In addition, many studies have shown that 
higher doses lead to greater pain control.63-65 However, a high 
dose of more than 90 Gy is related to a higher complication rate 
with similar pain control effects; hence, they are not usually 
used.5,6 Recently, a dose between 80 and 90 Gy is generally used, 
with modification depending the circumstances.
CONCLUSION
GKRS has been used for TN for a long time with low complica-
tion rates and high success rates. Over time, technical refine-
ments have improved its safety and efficacy. GKRS is being 
increasingly used as a primary intervention for TN for patients 
who cannot undergo surgery due to medical comorbidities and 
age or for those who refuse invasive therapy. To further increase 
safety and efficiency, discussions are underway on the treat-
ment policy to be applied. In the future, advances in imaging 
modalities and in GKRS technique, as well as accumulation of 
long-term results and experience will yield better results of 
GRKS for TN.
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